Dr. Jonathan W. Rowland, MD

Dr. Rowland practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Rowland's NPI, 1104358563, was assigned on April 3, 2017. Dr. Rowland graduated from Joe R. & Teresa Lozano Long School of Medicine in 2017. Dr. Rowland holds Texas license T0613.

Dr. Rowland's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Rowland's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Rowland is also affiliated with UCI Health - Orange. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Rowland to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowland practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Rowland's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Rowland is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Rowland's licenses on file in 3 states: Texas, California and Michigan.

CMS data shows 547 Medicare services from Dr. Rowland across 8 procedure codes in 2024, for 358 Medicare patients. Medicare paid $48,646 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 358 Medicare patients who saw Dr. Rowland in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 10% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rowland's median patient age at 67, with 57% women.

In 2024, Dr. Rowland wrote 105 Medicare Part D claims for 74 patients. 94% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $189 in total drug cost. In 2022, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Rowland for performance year 2024, reported as part of a group. Dr. Rowland accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Rowland, published from 2018 to 2025. Dr. Rowland has published most often in Clin Pract Cases Emerg Med. Dr. Rowland's most frequent co-authors are Theodora Anagnostou, MD, Robert Russell Ehrman, MD and Philip A. Friedlander, MD.

Dr. Rowland graduated from Joe R. & Teresa Lozano Long School of Medicine in 2017.

Dr. Rowland is in network with 4 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.